Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Sarepta Therapeutics (SRPT) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 39 quarters since 2012. Compare with SRPT stock chart to see long term trends.

SRPT Stock Compared to Quarterly

SRPT Income Statement

Revenue, Net:189406000
Revenue Per Share:2.18
Selling, General & Admin Expense:61127000
Research & Development Expense:139115000
Total Operating Expenses:223864000
Operating Income:-47907000
Income Taxes:237000
Net Income:-48144000
Earnings Per Share, Basic:-0.6
Shares Outstanding, Basic Avg:87076918

SRPT Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:10495000
Change in Accounts Receiveable:22267000
Net Cash from Operations:-124329000
Net Cash from Financing Activities:5902000
Property, Plant & Equipment Purchases:9241000
Net Cash from Investing Activities:20265000
Net Change in Cash & Equivalents:-98162000

SRPT Balance Sheet

Cash and Cash Equivalents:1608400000
Short-Term Investments:0
Accounts Receivable, Net:149787000
Inventories:288469000
Total Current Assets:2185310000
Property, Plant & Equipment, Net:199249000
Total Assets:2662218000
Accounts Payable:44163000
Total Short-Term Liabilities:373443000
Total Liabilities:2192690000

Insider Trading

Change
Value
Transaction
SEC Form 4
Rodino-Klapac Louise   Head of R&D, CSO
3,780 sh at $79
$299,867
Buy
INGRAM DOUGLAS S   President & CEO
25,026 sh at $80
$2,000,578
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
7,480,651 sh
24,249 sh
0%
$691,811
$112,150
Janus Henderson Group Plc
7,398,598 sh
503,833 sh
7%
$684,205
$148,190
Sands Capital Management, LLC
5,566,103 sh
-41,045 sh
-1%
$514,753
$78,853
Blackrock Inc.
4,760,218 sh
-106,133 sh
-2%
$440,224
$61,914
FMR LLC
4,151,448 sh
-275,750 sh
-6%
$383,926
$39,755
Capital Research Global Investors
2,542,191 sh
-2,208,578 sh
-46%
$235,102
-$134,223
Avoro Capital Advisors LLC
2,500,000 sh
100,000 sh
4%
$231,200
$44,624
Bank Of New York Mellon Corp
1,957,965 sh
-22,824 sh
-1%
$181,073
$27,086
Point72 Asset Management, L.P.
1,846,000 sh
1,427,400 sh
341%
$170,718
$138,176
State Street Corp
1,792,094 sh
105,749 sh
6%
$165,733
$34,637
JPMorgan Chase & Co
1,513,403 sh
207,061 sh
16%
$139,959
$38,404
Wellington Management Group Llp
1,399,462 sh
-107,210 sh
-7%
$129,421
$12,292
Casdin Capital, LLC
1,100,000 sh
215,000 sh
24%
$101,728
$32,928
Geode Capital Management, LLC
984,953 sh
665 sh
0%
$91,088
$14,570
Ameriprise Financial Inc
943,449 sh
-172,341 sh
-15%
$87,554
$813
First Trust Advisors Lp
929,208 sh
56,916 sh
7%
$85,933
$18,104
Goldman Sachs Group Inc
872,995 sh
850,395 sh
3763%
$80,734
$78,977
Credit Suisse Ag/
836,125 sh
774,925 sh
1266%
$77,325
$72,567
Citadel Advisors LLC
771,804 sh
569,704 sh
282%
$71,377
$55,666
Price T Rowe Associates Inc /Md/
709,444 sh
-11,748 sh
-2%
$65,609
$9,544

Data imported from Sarepta Therapeutics Inc SEC filings. Check original filings before making any investment decision.